Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis
Clinical trial NCT03517540 · COMPLETED
Trial details
- NCT number
- NCT03517540
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-11
- Primary completion
- 2020-09-15
- Enrollment
- 193
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.